Wiesława Dominika Wranik

7PUBLICATIONS
11CO-AUTHORS
Cancer diagnosisSocial determinants of healthChemotherapyPrimary health careGeneral practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 26, 2024
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Pam Takhar, Marc Geirnaert, Scott Gavura

|Jun 24, 2021
The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best-worst scaling approach.

Wiesława Dominika Wranik, Ronaldo-Raul Székely, Susanne Mayer

|Sep 01, 2018
Drug attributes associated with the selection of drugs for reimbursement: a pilot stated preferences experiment with Canadian stakeholders.

Wiesława Dominika Wranik, Christopher Skedgel, Min Hu

|Aug 15, 2018
Funding models and medical dominance in interdisciplinary primary care teams: qualitative evidence from three Canadian provinces.

Wiesława Dominika Wranik, Susan Marie Haydt

|Jan 22, 2018
The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian Oncology Drug Review 2011-2017.

Chris Skedgel, Dominika Wranik, Min Hu

|May 17, 2017
Funding and remuneration of interdisciplinary primary care teams in Canada: a conceptual framework and application.

W Dominika Wranik, Susan M Haydt, Alan Katz

Pageof 2

Frequent Collaborators

2 joint publications

Christopher Skedgel

2 joint publications

Min Hu

1 joint publications

Ronaldo-Raul Székely

1 joint publications

Susanne Mayer